IA
CTIC

IFP Advisors’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

IFP Advisors’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2
Closed – – 4134
2018
Q3 		$0 Hold
2
– – ﹤0.01% 4190
2018
Q2 		$0 Hold
2
– – ﹤0.01% 4285
2018
Q1 		$0 Hold
2
– – ﹤0.01% 3943
2017
Q4 		$0 Sell
2
-111
-98% -$325 ﹤0.01% 4398
2017
Q3 		$0 Sell
113
-3
-3% -$10 ﹤0.01% 4405
2017
Q2 		$0 Hold
116
– – ﹤0.01% 4403
2017
Q1 		$0 Sell
116
-1
-0.9% -$5 ﹤0.01% 4341
2016
Q4 		$0 Buy
117
+3
+3% +$12 ﹤0.01% 4331
2016
Q3 		$0 Hold
114
– – ﹤0.01% 4250
2016
Q2 		$0 Buy
+114
New +$523 ﹤0.01% 4276
2016
Q1 		– Sell
-3
Closed – – 4367
2015
Q4 		$0 Buy
+3
New +$40 ﹤0.01% 3948

Other funds holding CTIC

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $114M AUM 77.6% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return